Autologous stem cell transplantation in patients who object to a blood transfusion: contribution of new pharmacological haematopoiesis support. (opens new window)

Al-Nawakil C, Quarre MC, Heshmati F, Deau B, Park S, Dreyfus F, Bouscary D, Tamburini J.

Źródło‎: Br J Haematol 2013;161(5):738-40.

Indeks‎: PubMed 23480574

DOI‎: 10.1111/bjh.12284

https://www.ncbi.nlm.nih.gov/pubmed/23480574 (opens new window)

Autologous stem-cell transplantation can be performed safely without the use of blood-product support. (opens new window)

Ballen KK, Becker PS, Yeap BY, Matthews B, Henry DH, Ford PA.

Źródło‎: J Clin Oncol 2004;22(20):4087-94.

Indeks‎: PubMed 15353543

DOI‎: 10.1200/JCO.2004.01.144

https://www.ncbi.nlm.nih.gov/pubmed/15353543 (opens new window)

Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients. (opens new window)

Beck A, Lin R, Reza Rejali A, Rubens M, Paquette R, Vescio R, Merin N, Guerrero M, Federizo Y, Lua M, Uy L, Hernandez L, Allred M, Legaspi R, Leaverton M, Oliva S, Castillo R, Dean L, Bourke J, Cooper S, Gharapetian S, Causin J, Lopiccolo C, Ann Snoussi L, VanStrien P, Lill M, Linhares YP

Źródło‎: Bone Marrow Transplant 2020;55(6):1059-67.

Indeks‎: PubMed 31898692

DOI‎: 10.1038/s41409-019-0777-9

https://www.ncbi.nlm.nih.gov/pubmed/31898692 (opens new window)

The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem cell transplantation without the use of blood products. (opens new window)

Ciurea S, Beri R, Dobogai L, Chunduri S, Mahmud N, Rondelli D, Peace D.

Źródło‎: Bone Marrow Transplant 2006;37(3):325-7.

Indeks‎: PubMed 16314850

DOI‎: 10.1038/sj.bmt.1705223

https://www.ncbi.nlm.nih.gov/pubmed/16314850 (opens new window)

Hematopoietic stem cell transplantation without the use of blood components by the patient's choice: experience of 2 Brazilian centers. (opens new window)

da Silva RL, da Silva LAM, Geraldo BLDSS, Simões AA, Almeida MSS, Fernandes PA, Simões CM, Russo FT, Okada LY, Cavalcante JN, Lopes MAVF, Macedo RA, Macedo MCMA

Źródło‎: Biol Blood Marrow Transplant 2020;26(3):458-62.

Indeks‎: PubMed 31669397

DOI‎: 10.1016/j.bbmt.2019.10.018

https://www.ncbi.nlm.nih.gov/pubmed/31669397 (opens new window)

Transfusion challenges in hematology oncology and hematopoietic stem cell transplant - literature review and local experience. (opens new window)

Elemary M, Seghatchian J, Stakiw J, Bosch M, Sabry W, Goubran H

Źródło‎: Transfus Apher Sci 2017;56(3):317-21.

Indeks‎: PubMed 28642120

DOI‎: 10.1016/j.transci.2017.05.022

https://www.ncbi.nlm.nih.gov/pubmed/28642120 (opens new window)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (opens new window)

Ford PA, Grant SJ, Mick R, Keck G.

Źródło‎: J Clin Oncol 2015;33(15):1674-9.

Indeks‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (opens new window)

Myeloablative chemotherapy and autologous stem cell transplantation without the use of blood products. (opens new window)

Jamal F, Lim SW, Vescio R, Pepkowitz S, Van Strien P, Hoshal K, Lill MC.

Źródło‎: Biol Blood Marrow Transplant 2005;11(2 Suppl 1):66-7.

DOI‎: 10.1016/j.bbmt.2004.12.199

http://www.bbmt.org/article/S1083-8791(04)00851-1/fulltext (opens new window)

Safety and survival outcomes for bloodless transplantation in patients with myeloma. (opens new window)

Joseph NS, Kaufman JL, Boise LH, Valla K, Almaula DK, Obidike CO, Langston AA, Waller EK, Khoury HJ, Flowers CR, Graiser M, Heffner LT, Lonial S, Nooka AK

Źródło‎: Cancer 2019;125(2):185-93.

Indeks‎: PubMed 30480777

DOI‎: 10.1002/cncr.31677

https://www.ncbi.nlm.nih.gov/pubmed/30480777 (opens new window)

Bloodless tandem autologous transplant in Jehovah's Witness patients. (opens new window)

Khan R, Mott SL, Schultz A, Jethava YS, Tricot G

Źródło‎: Bone Marrow Transplant 2018. [Epub ahead of print]

Indeks‎: PubMed 29795417

DOI‎: 10.1038/s41409-018-0132-6

https://www.ncbi.nlm.nih.gov/pubmed/29795417 (opens new window)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (opens new window)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Źródło‎: Bone Marrow Transplant 2003;32(4):433-6.

Indeks‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (opens new window)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (opens new window)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Źródło‎: Bone Marrow Transplant 2005;36(8):715-20.

Indeks‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (opens new window)

SCT in Jehovah's Witnesses: the bloodless transplant. (opens new window)

Sloan JM, Ballen K.

Źródło‎: Bone Marrow Transplant 2008;41(10):837-44.

Indeks‎: PubMed 18246110

DOI‎: 10.1038/bmt.2008.5

https://www.ncbi.nlm.nih.gov/pubmed/18246110 (opens new window)